Table 1.

Patient characteristics (N = 38)

Sex, n (%)
Male	15 (39)
Female	23 (61)
Age, y
Median	34
Range	25-62
Race, n (%)
White	34 (89)
Black	2 (5)
Hispanic	1 (3)
Asian	1 (3)
Histology, n (%)
Nodular sclerosis	30 (79)
Mixed cellularity	4 (10.5)
Classical, not-otherwise-specified	4 (10.5)
Disease status, n (%)
Relapsed	17 (45)
Refractory	21 (55)
B symptoms, n (%)
Yes	13 (34)
No	25 (66%)
Performance status, n (%)
0	22 (58)
1	13 (34)
2	3 (8)
Prior chemotherapy regimens, n
Median	4
Range	2-9
Prior radiation therapy, n (%)
Yes	24 (63)
No	14 (37)
Prior stem cell transplantation, n (%)
Yes	33 (87)
No	5 (13)
Prior stem cell transplantation type, n (%)
Autologous	29 (76)
Syngeneic	1 (3)
Autologous and allogeneic	3 (8)
Time from last therapy to enrollment, mo
Median	3.5
Range	1-66